This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Sunesis Pharmaceuticals Inc (SNSS)

NASDAQ: Health Care

$1.13 -0.04 | -3.42%
09/04/15 - 4:00:00 PM ET
  • Prev Close: 1.17
  • Day's Open: 1.16
  • Volume: 319.52K
  • Avg Vol: 2.38M
  • Shares Outstanding: 75.47M
  • Mkt Cap: 88.30M
  • Div: --
  • Div Yield: --
  • P/E: N/A
  • EPS: -0.72
SNSS Day's Range
$1.12
$1.16
SNSS 52 Week Range
$0.84
$7.78
SNSS Business Summary
Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers.View SNSS key stats
Sunesis Pharmaceuticals Inc - SNSS - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Sunesis Pharmaceuticals Inc as a Sell with a ratings score of D-.
Report Snippet: We rate SUNESIS PHARMACEUTICALS INC (SNSS) a SELL. This is driven by a few notable weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. Among the areas we feel are negative, one of the most important has been a generally disappointing historical performance in the stock itself.
Rating: 1.67 out of 5, 'D-' Sell.
You can view the full analysis from the report here:
SNSS Rating Report
SNSS Performance as of Prev. Close
YTD
-54.12%
3-Mo
-52.82%
1-Yr
-84.52%
3-Yr
-63.09%
SNSS EPS Performance
1-Yr Ago
-0.72
2-Yrs Ago
-0.66
3-Yrs Ago
-0.91
SNSS Percentage in these ETFs
0.050%
0.002%
0.001%
0.000%
0.000%
SNSS News

SNSS Sunesis Pharmaceuticals Inc

Chart of SNSS

Analysts Ratings for SNSS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 3 3
Moderate Buy 0 0 0 0
Hold 5 5 3 3
Moderate Sell 0 0 0 0
Strong Sell 2 2 1 1
GET SNSS ANALYST REPORT

Brokerage Partners

SNSS Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs